{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T07:01:30Z","timestamp":1788678090012,"version":"build-2803163510"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.01556","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T05:56:04Z","timestamp":1596520564000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice"],"prefix":"10.3389","volume":"11","author":[{"given":"Hongfei","family":"Pi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra R.","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Woolford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia C.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Trott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiodun D.","family":"Ogunniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1021\/acs.jmedchem.5b01797","article-title":"Robenidine analogues as Gram-positive antibacterial agents.","volume":"59","author":"Abraham","year":"2016","journal-title":"J. Med. Chem."},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02690-16","article-title":"Potential toxicity of polymyxins in human lung epithelial cells.","volume":"61","author":"Ahmed","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4161\/viru.23326","article-title":"Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment?","volume":"4","author":"Bhattacharya","year":"2013","journal-title":"Virulence"},{"key":"B4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ja.2016.146","article-title":"Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.","volume":"70","author":"Brown","year":"2017","journal-title":"J. Antibiot."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-375","article-title":"Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study.","volume":"12","author":"Cardoso","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"B6","year":"2019","journal-title":"Antibiotic Resistance Threats in the United States, 2019."},{"key":"B7","year":"2017","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI standard M100."},{"key":"B8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1021\/bc500094d","article-title":"Probing the penetration of antimicrobial polymyxin lipopeptides into Gram-negative bacteria.","volume":"25","author":"Deris","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.phymed.2012.08.010","article-title":"Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells.","volume":"19","author":"Eid","year":"2012","journal-title":"Phytomedicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1128\/aac.44.8.2086-2092.2000","article-title":"Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria.","volume":"44","author":"Friedrich","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","article-title":"Antibiotic resistance.","volume":"10","author":"Frieri","year":"2017","journal-title":"J. Infect. Public Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02947","article-title":"Anti-Listeria activities of linalool and its mechanism revealed by comparative transcriptome analysis.","volume":"10","author":"Gao","year":"2019","journal-title":"Front. Microbiol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ijantimicag.2010.11.014","article-title":"Multidrug-resistant Gram-negative bacteria: how to treat and for how long.","volume":"36","author":"Giamarellou","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jphp.12326","article-title":"Synergistic antibacterial activity of the combination of the alkaloid sanguinarine with EDTA and the antibiotic streptomycin against multidrug resistant bacteria.","volume":"67","author":"Hamoud","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1128\/aac.00310-10","article-title":"Evaluation of biophotonic imaging to estimate bacterial burden in mice infected with highly virulent compared to less virulent Streptococcus pneumoniae serotypes.","volume":"54","author":"Henken","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00837","article-title":"In vitro antimicrobial activity of robenidine, ethylenediaminetetraacetic acid and polymyxin B nonapeptide against important human and veterinary pathogens.","volume":"10","author":"Khazandi","year":"2019","journal-title":"Front. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/10915810290096522","article-title":"Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA.","volume":"21","author":"Lanigan","year":"2002","journal-title":"Int. J. Toxicol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-019-00130-8","article-title":"The small-molecule antibiotics pipeline: 2014-2018.","volume":"18","author":"Lepore","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11010-007-9690-4","article-title":"Mesosome formation is accompanied by hydrogen peroxide accumulation in bacteria during the rifampicin effect.","volume":"311","author":"Li","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01146","article-title":"Synergistic combination of polymyxin B and enrofloxacin induced metabolic perturbations in extensive drug-resistant Pseudomonas aeruginosa.","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00028-18","article-title":"Polymyxin B in combination with enrofloxacin exerts synergistic killing against extensively drug-resistant Pseudomonas aeruginosa.","volume":"62","author":"Lin","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2012.27.2.128","article-title":"Current epidemiology and growing resistance of Gram-negative pathogens.","volume":"27","author":"Livermore","year":"2012","journal-title":"Korean J. Intern. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.bbamem.2015.05.008","article-title":"Riccardin C derivatives cause cell leakage in Staphylococcus aureus.","volume":"1848","author":"Morita","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183457","article-title":"Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.","volume":"12","author":"Ogunniyi","year":"2017","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200195","article-title":"Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing.","volume":"13","author":"Ogunniyi","year":"2018","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens.","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10096-013-1875-z","article-title":"In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.","volume":"32","author":"Phee","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations.","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/acsinfecdis.5b00085","article-title":"Antimicrobial activity and toxicity of the major lipopeptide components of polymyxin B and colistin: last-line antibiotics against multidrug-resistant Gram-negative bacteria.","volume":"1","author":"Roberts","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens.","volume":"2016","author":"Santajit","year":"2016","journal-title":"BioMed Res. Int."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.05041-11","article-title":"Combination therapy for treatment of infections with Gram-negative bacteria.","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/s1473-3099(18)30513-9","article-title":"Analysis of the clinical antibacterial and antituberculosis pipeline.","volume":"19","author":"Theuretzbacher","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure\u2013activity relationships of polymyxin antibiotics.","volume":"53","author":"Velkov","year":"2010","journal-title":"J. Med. Chem."},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180474","article-title":"Reversing resistance to counter antimicrobial resistance in the World Health Organisation\u2019s critical priority of most dangerous pathogens.","volume":"39","author":"Venter","year":"2019","journal-title":"Biosci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature02173","article-title":"An ABC transporter with a secondary-active multidrug translocator domain.","volume":"426","author":"Venter","year":"2003","journal-title":"Nature"},{"key":"B36","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats.","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111910","article-title":"Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors.","volume":"186","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature.2017.21550","article-title":"The drug-resistant bacteria that pose the greatest health threats.","volume":"543","author":"Willyard","year":"2017","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/509555a","article-title":"Policy: an intergovernmental panel on antimicrobial resistance.","volume":"509","author":"Woolhouse","year":"2014","journal-title":"Nat. News"},{"key":"B40","year":"2019","journal-title":"WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR): Critically Important Antimicrobials for Human Medicine 6th Revision 2018."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0596-8","article-title":"Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.","volume":"18","author":"Zilberberg","year":"2014","journal-title":"Crit. Care"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01556\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T05:56:08Z","timestamp":1596520568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01556\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":41,"alternative-id":["10.3389\/fmicb.2020.01556"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.01556","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"article-number":"1556"}}